A utility approach to individualized optimal dose selection using biomarkers

DOI10.1002/BIMJ.201900030MaRDI QIDQ3299111zbMATH OpenOpenAlexWikidataFDO

Authors Pin Li, Spring Kong, Shruti Jolly, M. Schipper, Jeremy M. G. Taylor

Publication date 17 July 2020

Published in Biometrical Journal (Search for Journal in Brave)

Full work available at URL https://hdl.handle.net/2027.42/154301

zbMATH Keywords

utilityoptimal treatment regimepersonalized medicineconstrained LASSOefficacy toxicity trade-off

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/II Trials
• Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates
• Bayesian dose-finding in two treatment cycles based on the joint utility of efficacy and toxicity
• Clinical trials for personalized dose finding
• scientific article; zbMATH DE number 2242805

Cited in

(4)

• Utility based approach in individualized optimal dose selection using machine learning methods
• Bayesian adaptive design of early-phase clinical trials for precision medicine based on cancer biomarkers
• scientific article; zbMATH DE number 5257966 (Why is no real title available?)
• Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates

This page was built for publication: A utility approach to individualized optimal dose selection using biomarkers

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3299111)